ANTAGEN BIOSCIENCES INC — Department of Health and Human Services SBIR Phase II: ODCDC
ANTAGEN BIOSCIENCES INC — SBIR Phase II award from Department of Health and Human Services.
- Amount
- $1,000,000
- Agency
- Department of Health and Human Services · Centers for Disease Control and Prevention
- Program / Phase
- SBIR · Phase II
- Topic
- ODCDC
- NAICS
- —
- Place of performance
- MA
- Period
- —
Description
Atagen will collaborate with MBL to consolidate resources and propose a streamlined Phase II research program as follows AIM Comparison of to C in vitro and in vivo to select lead Mab for development AIM Standardize animal model s and establish non inferiority lead Mab to standard of care equine DAT in vivo efficacy study AIM Toxicology studies with lead Mab